Turning Point Brands recently reported fourth-quarter 2025 sales of US$121.01 million and full-year sales of US$463.06 million, alongside 2026 Modern Oral gross revenue guidance of US$220 million to US$240 million and net revenue guidance of US$180 million to US$190 million. At the same time, FRE® Nicotine Pouches’ new NASCAR Cup Series partnership with 23XI Racing and driver Riley Herbst signals a push to broaden brand reach and retail penetration, particularly in the Las Vegas market. We’ll now examine how the upbeat Modern Oral revenue guidance and NASCAR-linked marketing push may influence Turning Point Brands’ investment narrative.
The future of work is here. Discover the 30 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.
Turning Point Brands Investment Narrative Recap
To own Turning Point Brands, you need to believe that Modern Oral nicotine pouches can keep growing as a profit engine while regulatory and competitive pressures remain manageable. The new 2026 Modern Oral revenue guidance and FRE’s NASCAR partnership both speak directly to that growth story, but they do not change the core near term catalyst of execution on distribution and marketing spend, or the key risk that regulatory or category pressures could still disrupt Modern Oral economics.
The 2026 guidance for Modern Oral gross revenue of US$220 million to US$240 million, alongside net revenue of US$180 million to US$190 million, is the most relevant development here because it frames how meaningful the category is expected to be for Turning Point Brands in the near term. It sits against a backdrop of higher spend on sales force and marketing, including programs like the NASCAR tie up, which keeps the balance between growth ambition and margin pressure firmly in focus for shareholders.
Yet investors should be aware that the same Modern Oral focus that underpins the growth story also leaves Turning Point Brands more exposed if…
Read the full narrative on Turning Point Brands (it’s free!)
Turning Point Brands’ narrative projects $745.7 million revenue and $100.8 million earnings by 2028.
Uncover how Turning Point Brands’ forecasts yield a $132.50 fair value, a 46% upside to its current price.
Exploring Other Perspectives
TPB 1-Year Stock Price Chart
Four fair value estimates from the Simply Wall St Community span roughly US$108 to US$159, showing how far apart individual views can be. As you weigh those opinions, it is worth keeping in mind that Turning Point Brands’ growth plan leans heavily on Modern Oral nicotine pouches, which also concentrates regulatory and competitive risk in a single category.
Explore 4 other fair value estimates on Turning Point Brands – why the stock might be worth just $108.15!
Form Your Own Verdict
Don’t just follow the ticker – dig into the data and build a conviction that’s truly your own.
A great starting point for your Turning Point Brands research is our analysis highlighting 4 key rewards that could impact your investment decision.Our free Turning Point Brands research report provides a comprehensive fundamental analysis summarized in a single visual – the Snowflake – making it easy to evaluate Turning Point Brands’ overall financial health at a glance.Want Some Alternatives?
Right now could be the best entry point. These picks are fresh from our daily scans. Don’t delay:
This article by Simply Wall St is general in nature. We provide commentary based on historical data
and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your
financial situation. We aim to bring you long-term focused analysis driven by fundamental data.
Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.
Simply Wall St has no position in any stocks mentioned.
Valuation is complex, but we’re here to simplify it.
Discover if Turning Point Brands might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com